Jadhav Indrayani, Chakole Swarupa
Medicine and Surgery, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Community Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Cureus. 2023 Sep 17;15(9):e45428. doi: 10.7759/cureus.45428. eCollection 2023 Sep.
Type 1 diabetes mellitus (T1DM) has a significant effect on the growth of children. The disease has a negative effect on growth when considered in relation to the time period and metabolic control. Studies in this review have suggested debilitated growth in children with T1DM and have a few anomalies in the growth hormone (GH)-insulin-like growth factor-1 (IGF-1) axis when compared to fit children. Some studies show that children with T1DM were taller before the onset of the disease and during early diagnosis. Moreover, the linear growth depends on the interaction between the gonadotropin hormone, luteinizing hormone (LH), follicle-stimulating hormone (FSH), and sex steroid hormones axis and GH-IGF-1; there's a rise in GH during puberty, which has an effect on the estrogen and testosterone, which leads to the pulsatile secretion of GH, this increment leads to insulin resistance. These studies suggest short stature in girls, and some suggest in both. The final height in boys was unchanged, but a slight decline was observed in girls. This review aims to provide the latest understanding of impaired height in children with T1DM. The most accepted and effective treatment of impaired growth is the administration of long-acting insulin or continuous rapid-acting insulin. However, height was affected by the administration of good basal insulin at puberty and was unaffected by the continuous subcutaneous insulin injection. Hence, new technologies are the therapeutic regimen in children, especially the prepubertal age group; it will be interesting to see their effects on growth patterns in these children with T1DM.
1型糖尿病(T1DM)对儿童生长有显著影响。从时间段和代谢控制方面考虑,该疾病对生长有负面影响。本综述中的研究表明,与健康儿童相比,T1DM患儿生长发育不良,且生长激素(GH)-胰岛素样生长因子-1(IGF-1)轴存在一些异常。一些研究表明,T1DM患儿在疾病发作前和早期诊断期间身高较高。此外,线性生长取决于促性腺激素、黄体生成素(LH)、卵泡刺激素(FSH)和性类固醇激素轴与GH-IGF-1之间的相互作用;青春期GH会升高,这会影响雌激素和睾酮,导致GH脉冲式分泌,这种增加会导致胰岛素抵抗。这些研究表明女孩身材矮小,有些研究表明男孩和女孩都存在身材矮小。男孩的最终身高没有变化,但女孩的最终身高略有下降。本综述旨在提供对T1DM患儿身高受损的最新认识。对于生长发育受损,最被认可且有效的治疗方法是使用长效胰岛素或持续速效胰岛素。然而,青春期使用良好的基础胰岛素会影响身高,而持续皮下胰岛素注射则不会影响身高。因此,新技术是儿童尤其是青春期前年龄组的治疗方案;观察它们对这些T1DM患儿生长模式的影响将会很有趣。